BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 35147926)

  • 1. Risk of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis: an updated systematic review and meta-analysis of observational studies.
    Bellinato F; Gisondi P; Mantovani A; Girolomoni G; Targher G
    J Endocrinol Invest; 2022 Jul; 45(7):1277-1288. PubMed ID: 35147926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome, non-alcoholic fatty liver disease and liver stiffness in psoriatic arthritis and psoriasis patients.
    Ortolan A; Lorenzin M; Tadiotto G; Russo FP; Oliviero F; Felicetti M; D'Incà R; Favero M; Piaserico S; Doria A; Ramonda R
    Clin Rheumatol; 2019 Oct; 38(10):2843-2850. PubMed ID: 31254236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of non-alcoholic fatty liver disease in patients with psoriasis: a systematic review and meta-analysis.
    Candia R; Ruiz A; Torres-Robles R; Chávez-Tapia N; Méndez-Sánchez N; Arrese M
    J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):656-62. PubMed ID: 25418531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between nonalcoholic fatty liver disease and colorectal tumours in asymptomatic adults undergoing screening colonoscopy: a systematic review and meta-analysis.
    Mantovani A; Dauriz M; Byrne CD; Lonardo A; Zoppini G; Bonora E; Targher G
    Metabolism; 2018 Oct; 87():1-12. PubMed ID: 29935236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-Alcoholic Fatty Liver Disease Is Associated With Reduced Glomerular Filtration Rate in Patients With Chronic Plaque Psoriasis.
    Bellinato F; Goio I; Malara G; Rosato A; Targher G; Girolomoni G; Gisondi P
    J Cutan Med Surg; 2022; 26(3):249-255. PubMed ID: 34894782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and risk of nonalcoholic fatty liver disease among adult psoriatic patients: A systematic review, meta-analysis, and trial sequential analysis.
    Hu J; Shao Y; Gui C; Xiao Y; Li L; Li Z
    Medicine (Baltimore); 2024 May; 103(18):e38007. PubMed ID: 38701269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis.
    Mantovani A; Zaza G; Byrne CD; Lonardo A; Zoppini G; Bonora E; Targher G
    Metabolism; 2018 Feb; 79():64-76. PubMed ID: 29137912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Primary Hypothyroidism and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
    Mantovani A; Nascimbeni F; Lonardo A; Zoppini G; Bonora E; Mantzoros CS; Targher G
    Thyroid; 2018 Oct; 28(10):1270-1284. PubMed ID: 30084737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals.
    Mantovani A; Petracca G; Beatrice G; Tilg H; Byrne CD; Targher G
    Gut; 2021 May; 70(5):962-969. PubMed ID: 32938692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis.
    Mantovani A; Petracca G; Beatrice G; Csermely A; Lonardo A; Schattenberg JM; Tilg H; Byrne CD; Targher G
    Gut; 2022 Jan; 71(1):156-162. PubMed ID: 33303564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis.
    Mantovani A; Csermely A; Petracca G; Beatrice G; Corey KE; Simon TG; Byrne CD; Targher G
    Lancet Gastroenterol Hepatol; 2021 Nov; 6(11):903-913. PubMed ID: 34555346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis.
    Miele L; Vallone S; Cefalo C; La Torre G; Di Stasi C; Vecchio FM; D'Agostino M; Gabrieli ML; Vero V; Biolato M; Pompili M; Gasbarrini G; Rapaccini G; Amerio P; De Simone C; Grieco A
    J Hepatol; 2009 Oct; 51(4):778-86. PubMed ID: 19664838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between Helicobacter pylori infection and risk of nonalcoholic fatty liver disease: An updated meta-analysis.
    Mantovani A; Turino T; Altomari A; Lonardo A; Zoppini G; Valenti L; Tilg H; Byrne CD; Targher G
    Metabolism; 2019 Jul; 96():56-65. PubMed ID: 31047909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis.
    Mantovani A; Byrne CD; Bonora E; Targher G
    Diabetes Care; 2018 Feb; 41(2):372-382. PubMed ID: 29358469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Prevalence of Nonalcoholic Fatty Liver Disease and Related Metabolic Comorbidities Was Associated with Age at Onset of Moderate to Severe Plaque Psoriasis: A Cross-Sectional Study.
    Xu X; Su L; Gao Y; Ding Y
    PLoS One; 2017; 12(1):e0169952. PubMed ID: 28099469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies.
    Mantovani A; Petracca G; Beatrice G; Csermely A; Tilg H; Byrne CD; Targher G
    Gut; 2022 Apr; 71(4):778-788. PubMed ID: 33685968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between Non-Alcoholic Fatty Liver Disease and Psoriasis: A Novel Hepato-Dermal Axis?
    Mantovani A; Gisondi P; Lonardo A; Targher G
    Int J Mol Sci; 2016 Feb; 17(2):217. PubMed ID: 26861300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin Levels and Non-Alcoholic Fatty Liver Disease in Chronic Plaque Psoriasis: An Analytical Case Control Study.
    Yadav V; Mendiratta V; Agrawal A; Bisherwal K; Singh R; Meena AK
    Indian J Dermatol; 2023; 68(4):377-384. PubMed ID: 37822394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between non-alcoholic fatty liver disease and risk of atrial fibrillation in adult individuals: An updated meta-analysis.
    Mantovani A; Dauriz M; Sandri D; Bonapace S; Zoppini G; Tilg H; Byrne CD; Targher G
    Liver Int; 2019 Apr; 39(4):758-769. PubMed ID: 30657626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis.
    Gisondi P; Targher G; Zoppini G; Girolomoni G
    J Hepatol; 2009 Oct; 51(4):758-64. PubMed ID: 19560226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.